Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St -- Ignore unavailable to you. Want to Upgrade?

To: KLH who wrote (439)	10/20/1998 11:05:00 AM
From: Jeffrey L. Henken	Respond to of 939

I see absolutely no reason, given the current market conditions and the recover in the biotech group as a whole, that a buy here would not be a wise move. Biotech stocks have cost unwary investors a lot of money over the years but they do have a tendency to move as a group. The current move is upward. I would not hesitate to commit some funds here if you have some available cash but not too much. I would not make biotechs too large a portion of a stock portfolio. Since you are in TIE, I think you would agree. Take a look at Cortex pharmacueticals (CORX) as an example of the risks involved. The nice thing about GENZL is they have plenty of cash and are already manufacturing and selling product. Here are URLs for those that want to look at the risk and rewards of investing in biotechs based on these two examples: quote.yahoo.com Regards, Jeff

To: KLH who wrote (439)	10/23/1998 11:34:00 AM
From: Jeffrey L. Henken	Respond to of 939

Anyone else been watching the disk drive industry for signs of an upturn? Check out this story from the CDA Investnet site: KOMAG INC. - KMAG -- Conditions for the disk drive industry have been dismal at best, as reflected in stock prices for the industry across the board. In fact, even with the stocks trading at depressed prices, most analysts caution would-be investors against being lured by apparent rock-bottom prices. While there is some indication that industry fundamentals may be solidifying, the only meaningful change in recommendations is a lack of expectations of further earnings disappointments. Despite this discouraging outlook, a recent round of accumulation by Komag executives appears worthy of consideration. Granted, insiders at other companies in the disk drive industry were buying shares at what appeared to be bargain prices earlier in the year, only to see their stocks continue to fall. However, the number of shares being purchased by "seasoned" executives seems to confirm that negative news is not on the horizon. From August 6 to August 25, five executives purchased 110,000 shares at $2.88-$3.50 per share. Director Anthony Sun, a Board member since '83, bought 20,000 shares in his first open-market purchase since '91. Mr. Sun's affiliations with numerous tech-related companies appear to distinguish him as a seasoned industry insider. Director Irwin Federman's 20,000 share purchase was his first since initially filing in '88. Some of Mr. Federman's other affiliations include Western Digital, Advanced Micro Devices, and Sandisk. Director Craig Barrett, a Board member since '89 and an Intel executive since '74, bought 20,000 shares. Director Masayoshi Takebayashi, a frequent seller in the past, purchased 20,000 shares in his first open-market buy since initially filing in '92. Finally, SVP & Chief Technical Officer Christopher Bajorek bought 30,000 shares-his first open-market buy since becoming a filer in '96. Adding to the significance of this activity is that Komag executives were selling shares when the stock was trading at its highs. Komag Inc. develops, manufactures and markets thin film media disks, primarily for storage medium for digital data in computer hard drive disks. cda.com Keep an eye on KMAG because there should be lots of upside left here: quote.yahoo.com It's down 1/8 at 4 7/8's currently. InvestRight Regards, Jeff